CTNNB1 and hepatocellular carcinoma: As previous study showed association of CTNNB1 (β-catenin) gene mutations and HCC with CIMP [29], β-catenin mutation was analyzed in our cohort and revealed that 22.5% (9/40) of HCCs harbored activating mutations (see Fig 5).